Literature DB >> 3037390

Plasma concentration and vascular effect of beta-endorphin in spontaneously hypertensive and Wistar Kyoto rats.

B Bucher, R Bettermann, P Illes.   

Abstract

In order to find out whether beta-endorphin (beta-E) is involved in the development of hypertension, we performed two series of experiments. Firstly, spontaneously hypertensive rats (SHR) and their normotensive Wistar Kyoto controls (WKY) were submitted to ether stress. Plasma concentrations of beta-endorphin-like immunoreactivity (beta-EI), adrenocorticotropin (ACTH) and alpha-melanotropin (alpha-MSH) were measured by radioimmunoassay. The basal concentration of beta-EI was similar in WKY and SHR, whereas WKY had higher levels of ACTH and lower levels of alpha-MSH than SHR. In both strains acute stress enhanced the plasma concentration of beta-EI to the same extent and with a similar time-course. The increase of plasma beta-EI coincided with a rise in ACTH but not alpha-MSH. Gel chromatography of beta-EI revealed that plasma extracts contain similar amounts of beta-lipotropin- (beta-LPH) and beta-E-sized immunoreactive components, and that acute stress elevated both forms of beta-EI. Secondly, isolated tail arteries of SHR and WKY were perfused and field stimulated with two pulses at 1 Hz. beta-E depressed stimulation-evoked vasoconstriction with the same potency in both strains. Thus, basal and stress-induced levels of beta-EI did not differ in SHR and WKY. Moreover, in the tail artery of both strains the sensitivity of presynaptic opioid receptors towards beta-E was almost identical. If the beta-E sensitivity of these receptors in other arteries of WKY and SHR is also similar a major role of the circulating peptide in the development of hypertension is rather unlikely.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037390     DOI: 10.1007/BF00165558

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

1.  Central alpha-activation by clonidine reduces plasma level of beta-endorphin in patients with essential hypertension.

Authors:  K Yasunari; Y Kanayama; M Kohno; K Murakawa; T Kawarabayashi; T Takeda; N Kotsugai; K Sato
Journal:  Life Sci       Date:  1985-10-21       Impact factor: 5.037

2.  Differential control of beta-endorphin/beta-lipotropin secretion from anterior and intermediate lobes of the rat pituitary gland in vitro.

Authors:  I Vemes; G H Mulder; P G Smelik; F J Tilders
Journal:  Life Sci       Date:  1980-11-10       Impact factor: 5.037

Review 3.  Cardiovascular effects of endogenous opiate systems.

Authors:  J W Holaday
Journal:  Annu Rev Pharmacol Toxicol       Date:  1983       Impact factor: 13.820

4.  Failure of naloxone to reduce clonidine-induced changes in blood pressure, heart rate and sympathetic nerve firing in cats.

Authors:  A T Shropshire; R L Wendt
Journal:  J Pharmacol Exp Ther       Date:  1983-03       Impact factor: 4.030

5.  Immunoreactive alpha-MSH and ACTH levels in rat plasma and pituitary.

Authors:  R Usategui; C Oliver; H Vaudry; G Lombardi; I Rozenberg; A M Mourre
Journal:  Endocrinology       Date:  1976-01       Impact factor: 4.736

6.  Presynaptic opioid receptor subtypes in the rabbit ear artery.

Authors:  P Illes; N Pfeiffer; I von Kügelgen; K Starke
Journal:  J Pharmacol Exp Ther       Date:  1985-02       Impact factor: 4.030

7.  Presynaptic inhibitory opioid delta- and kappa-receptors in a branch of the rabbit ileocolic artery.

Authors:  I Von Kügelgen; P Illes; D Wolf; K Starke
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

8.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland.

Authors:  R Guillemin; T Vargo; J Rossier; S Minick; N Ling; C Rivier; W Vale; F Bloom
Journal:  Science       Date:  1977-09-30       Impact factor: 47.728

9.  beta-Endorphin controls vasopressin release during foot shock-induced stress in the rat.

Authors:  W Knepel; D Nutto; H Anhut
Journal:  Regul Pept       Date:  1983-09

10.  Vasopressin stimulates release of beta-lipotropin and beta-endorphin in conscious rats as measured by radioimmunoassay of unextracted plasma.

Authors:  H Anhut; W Knepel; D Nutto; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-02       Impact factor: 3.000

View more
  4 in total

1.  Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.

Authors:  M Tschöpl; R C Miller; J Pelton; J C Stoclet; B Bucher
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

2.  Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery.

Authors:  B Bucher; S Ouedraogo; M Tschöpl; D Paya; J C Stoclet
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

3.  Inhibition of noradrenaline release by omega-conotoxin GVIA in the rat tail artery.

Authors:  B Clasbrummel; H Osswald; P Illes
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

4.  Role of cyclic AMP in the prejunctional alpha 2-adrenoceptor modulation of noradrenaline release from the rat tail artery.

Authors:  B Bucher; L Pain; J C Stoclet; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.